Aberrant Regulation of RAD51 Promotes Resistance of Neoadjuvant Endocrine Therapy in ER-positive Breast Cancer.
Sci Rep
; 9(1): 12939, 2019 09 10.
Article
in En
| MEDLINE
| ID: mdl-31506496
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Receptors, Estrogen
/
Gene Expression Regulation, Neoplastic
/
Drug Resistance, Neoplasm
/
Antineoplastic Agents, Hormonal
/
Aromatase Inhibitors
/
Rad51 Recombinase
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Sci Rep
Year:
2019
Document type:
Article
Affiliation country:
China